- Yield10 Bioscience filed for Chapter 11 bankruptcy and entered liquidation in 2024.
- In January 2025, Nufarm Limited acquired substantially all of Yield10's assets.
The transaction marked the end of Yield10's standalone operations as a crop-trait engineering company.
Assets acquired by Nufarm:
- Entire Camelina R&D portfolio.
- Intellectual property for:
- Omega-3 production
- Herbicide tolerance
- Bio-energy traits
- Early-stage bioplastics (PHA) research.
Integration and future plans:
- The Camelina platform was integrated into Nuseed, Nufarm's seed-technology division.
- Nuseed plans to expand omega-3 products for:
- Aquaculture
- Human nutrition
- Pharmaceutical applications
Company status:
- Yield10 Bioscience (formerly Metabolix) was delisted from Nasdaq in May 2024.
- The company was liquidated.
- Its stock transitioned to bankruptcy trading status under ticker YTENQ.
Additional sources:
- Nufarm and Nuseed corporate communications provide updates on the acquired technology platform.
- Yahoo Finance (YTENQ) provides historical financial and legal information.
There are no replies in this thread yet. Be the first to post a reply below: